Swedish Orphan Biovitrum Cash Flow Statement 2018-2024 | BIOVF

Fifteen years of historical annual cash flow statements for Swedish Orphan Biovitrum (BIOVF).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$279$329$384$354$350$278
$302$240$234$221$168$55.77
$105$73.93$61.68$14.17$43.06$-64.64
$407$314$296$235$211$-8.87
$0$0$0$0$0$0
$26.97$40.93$-37.08$-142.35$-48.56$-26.57
$0$0$0$0$0$0
$-136.36$-120.80$167$122$-127.70$-2.26
$-109.39$-79.87$130$-20.06$-176.26$-28.83
$422$462$638$568$384$241
$-38.38$-7.14$-5.13$-3.60$-3.91$-4.29
$-427.74$-139.24$-37.66$-415.40$-927.65$-61.85
$-1,599.42$0$0$0$-1,362.70$0
$0$0$0$0$0$0
$0$0$0$-13.08$0$-0.08
$0$0$0$-13.08$0$-0.08
$0$0$0$0$0$0
$-2,065.55$-146.37$-42.79$-432.08$-2,294.27$-66.24
$1,061$-239.72$-466.17$-158.27$1,680$-0.24
$-15.28$-13.18$-14.58$-12.86$-9.95$0
$1,045$-252.90$-480.74$-171.13$1,670$-0.24
$17.07$0$0$0$0$0
$17.07$0$0$0$0$0
$0$0$0$0$0$0
$542$-43.41$-40.93$0$0$0
$1,604$-296.41$-521.67$-171.13$1,670$-0.24
$-43.10$31.32$74.74$-36.30$-239.32$175
$0$0$0$0$0$0
$0$0$0$0$0$0